Glimepiride; Pioglitazone Hydrochloride Patent Expiration
Glimepiride; Pioglitazone Hydrochloride is Used for improving glycemic control in patients with type 2 diabetes. It was first introduced by Takeda Pharmaceuticals Usa Inc
Glimepiride; Pioglitazone Hydrochloride Patents
Given below is the list of patents protecting Glimepiride; Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Duetact | US6150383 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Duetact | US6211205 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Duetact | US6303640 | Pharmaceutical composition |
Aug 09, 2016
(Expired) | Takeda Pharms Usa |
| Duetact | US6329404 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Duetact | US7538125 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Duetact | US7700128 | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester | Jan 30, 2027 | Takeda Pharms Usa |
| Duetact | US8071130 | Solid preparation | Jun 08, 2028 | Takeda Pharms Usa |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Glimepiride; Pioglitazone Hydrochloride Generics
Several generic applications have been filed for Glimepiride; Pioglitazone Hydrochloride.
Given below is the list of companies who have filed for Glimepiride; Pioglitazone Hydrochloride generic.
1. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Glimepiride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG; 30MG | tablet | Prescription | ORAL | AB | Jan 4, 2013 |
| 4MG; 30MG | tablet | Prescription | ORAL | AB | Jan 4, 2013 |